| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a …
Over the last 12 months, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Citius Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,234,700 shares for transaction amount of $2M was made by Mazur Leonard L (Executive Chairman) on 2019‑09‑27.
| 2019-09-27 | Mazur Leonard L | Executive Chairman | 2.23M 13.7793% | $0.90 | $2M | +20.83% | ||
| 2019-09-27 | HOLUBIAK MYRON Z | President and CEO | 558,597 3.4443% | $0.90 | $500,000 | +20.83% | ||
| 2019-04-03 | Mazur Leonard L | Executive Chairman | 1.17M 6.2256% | $1.54 | $1.8M | -23.77% | ||
| 2019-04-03 | HOLUBIAK MYRON Z | President and CEO | 129,450 0.6917% | $1.54 | $200,000 | -23.77% | ||
| 2018-08-13 | Mazur Leonard L | Executive Chairman | 3.14M 27.0206% | $1.27 | $4M | -14.12% | ||
| 2018-08-13 | HOLUBIAK MYRON Z | President and CEO | 784,314 6.7551% | $1.27 | $1M | -14.12% | ||
| 2018-03-29 | Mazur Leonard L | Executive Chairman | 167,504 1.6135% | $2.98 | $499,999 | -51.29% | ||
| 2018-03-28 | HOLUBIAK MYRON Z | President and CEO | 2,915 0.0277% | $3.09 | $9,007 | -53.54% | ||
| 2017-12-19 | Mazur Leonard L | Executive Chairman | 213,106 2.6762% | $4.69 | $999,467 | -41.71% | ||
| 2017-08-24 | Mazur Leonard L | Executive Chairman | 11,000 0.2205% | $2.68 | $29,480 | +15.56% | ||
| 2017-08-08 | Mazur Leonard L | Executive Chairman | 421,400 11.6995% | $4.13 | $1.74M | +4.00% | ||
| 2016-03-30 | Mazur Leonard L | director | 10M 6.4441% | $0.60 | $6M | -74.93% |
| Mazur Leonard L | Executive Chairman | 10255343 37.3566% | $5.88M | 8 | 0 | <0.0001% |
| HOLUBIAK MYRON Z | President and CEO | 1992243 7.257% | $1.14M | 4 | 0 | <0.0001% |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$37,200,153 | 21 | -47.67% | $12.66M |
| Increased Positions | 17 | +47.22% | 1M | +188.84% |
| Decreased Positions | 10 | -27.78% | 82,979 | -13.29% |
| New Positions | 9 | New | 938,356 | New |
| Sold Out Positions | 4 | Sold Out | 20,873 | Sold Out |
| Total Postitions | 43 | +19.44% | 2M | +175.55% |
| Vanguard Group Inc | $141.00 | 0.79% | 166,390 | +86,287 | +107.72% | 2025-09-30 |
| Geode Capital Management, Llc | $102.00 | 0.57% | 119,771 | +43,676 | +57.4% | 2025-09-30 |
| Blackrock, Inc. | $59.00 | 0.33% | 69,851 | 0 | 0% | 2025-09-30 |
| Susquehanna International Group, Llp | $41.00 | 0.23% | 48,186 | +33,987 | +239.36% | 2025-09-30 |
| Northern Trust Corp | $23.00 | 0.13% | 27,025 | +12,652 | +88.03% | 2025-09-30 |
| Ubs Group Ag | $22.00 | 0.12% | 25,913 | -167,014 | -86.57% | 2025-09-30 |
| Newedge Advisors, Llc | $22.00 | 0.12% | 25,400 | +400 | +1.6% | 2025-09-30 |
| State Street Corp | $20.00 | 0.11% | 23,271 | 0 | 0% | 2025-09-30 |
| Two Sigma Investments, Lp | $18.00 | 0.1% | 21,803 | +8,929 | +69.36% | 2025-09-30 |
| Arkadios Wealth Advisors | $17.00 | 0.1% | 20,000 | 0 | 0% | 2025-09-30 |